{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:17:03Z","timestamp":1770139023965,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.pathol.2022.07.017","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:06:20Z","timestamp":1665140780000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-8890","authenticated-orcid":false,"given":"Caitlin","family":"Coombes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Hee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartik","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Shadbolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-2969","authenticated-orcid":false,"given":"Lillian","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6766-8345","authenticated-orcid":false,"given":"Dipti","family":"Talaulikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2022.07.017_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2022.07.017_bib2","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.28849","article-title":"Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006","volume":"135","author":"van Leeuwen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2022.07.017_bib3","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.017_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.017_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2022.07.017_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3324\/haematol.2014.116855","article-title":"The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection","volume":"100","author":"Arcaini","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.07.017_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/annonc\/mdv019","article-title":"Genetic lesions in diffuse large B-cell lymphomas","volume":"26","author":"Testoni","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2022.07.017_bib8","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2013-01-479865","article-title":"Analysis of FOXO1 mutations in diffuse large B-cell lymphoma","volume":"121","author":"Trinh","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.017_bib9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2022.07.017_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2022.07.017_bib11","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2022.07.017_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2022.07.017_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2022.07.017_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2022.07.017_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2022.07.017_bib16","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.017_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2022.07.017_bib18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1537-2995.2008.02054.x","article-title":"Blood donors with positive direct antiglobulin tests are at increased risk for cancer","volume":"49","author":"Rottenberg","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.pathol.2022.07.017_bib19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/eji.1830270616","article-title":"Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression","volume":"27","author":"Kuppers","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pathol.2022.07.017_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1385\/MO:22:4:327","article-title":"Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis","volume":"22","author":"Walsh","year":"2005","journal-title":"Med Oncol"},{"key":"10.1016\/j.pathol.2022.07.017_bib21","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajpath.2012.07.028","article-title":"Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype","volume":"181","author":"Sebastian","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2022.07.017_bib22","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pathol.2022.07.017_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","article-title":"Helicobacter pylori infection and gastric lymphoma","volume":"330","author":"Parsonnet","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2022.07.017_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/1055-9965.EPI-21-0875","article-title":"B-cell non-Hodgkin lymphoma (NHL) subtype risk associated with autoimmune conditions and polygenic risk scores (PRS)","volume":"31","author":"Wang","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pathol.2022.07.017_bib25","first-page":"191","article-title":"Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value","volume":"19","author":"Uskudar Teke","year":"2014","journal-title":"J\u00a0BUON"},{"key":"10.1016\/j.pathol.2022.07.017_bib26","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.7314\/APJCP.2015.16.14.6007","article-title":"Direct Coombs test positivity in B-chronic lymphoid leukemia: a marker of advanced clinical disease","volume":"16","author":"Abbas","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.pathol.2022.07.017_bib27","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/10428190903111930","article-title":"The negative prognostic significance of positive direct antiglobulin test in Chinese patients with chronic lymphocytic leukemia","volume":"50","author":"Xu","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2022.07.017_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.clml.2013.02.024","article-title":"Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?","volume":"13","author":"Ricci","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.pathol.2022.07.017_bib29","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2022.07.017_bib30","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.4049\/jimmunol.149.7.2337","article-title":"VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities","volume":"149","author":"Pascual","year":"1992","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2022.07.017_bib31","first-page":"231","article-title":"The immunoglobulin VH gene, VH4-21, specifically encodes autoanti-red cell antibodies against the I or i antigens","volume":"68","author":"Smith","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.pathol.2022.07.017_bib32","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1182\/blood.V78.9.2372.2372","article-title":"Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens","volume":"78","author":"Silberstein","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.017_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0955-3886(00)00031-X","article-title":"Molecular characterization of cold agglutinins","volume":"22","author":"Potter","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.pathol.2022.07.017_bib34","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.4049\/jimmunol.146.12.4385","article-title":"Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype","volume":"146","author":"Pascual","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2022.07.017_bib35","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.4049\/jimmunol.169.7.3777","article-title":"Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen","volume":"169","author":"Potter","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2022.07.017_bib36","doi-asserted-by":"crossref","first-page":"E2567","DOI":"10.1073\/pnas.1406974111","article-title":"Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity","volume":"111","author":"Sabouri","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2022.07.017_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2249.1996.d01-769.x","article-title":"Tracking of the V4-34 (VH4-21) gene in human tonsil reveals clonal isotype switch events and a highly variable degree of somatic hypermutation","volume":"105","author":"Chapman","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pathol.2022.07.017_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pathol.2022.07.017_bib39","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.07.017_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pathol.2022.07.017_bib41","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2022.07.017_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-017-0438-7","article-title":"Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38\/07 prospective clinical trial cohort","volume":"10","author":"Juskevicius","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.pathol.2022.07.017_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-kappaB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.pathol.2022.07.017_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2022.07.017_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2022.07.017_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semcancer.2016.07.003","article-title":"MALT lymphoma: a paradigm of NF-kappaB dysregulation","volume":"39","author":"Du","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.pathol.2022.07.017_bib47","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s00125-009-1331-x","article-title":"Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line","volume":"52","author":"Sarkar","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.pathol.2022.07.017_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1352458507087468","article-title":"Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination","volume":"14","author":"Hebb","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.pathol.2022.07.017_bib49","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3324\/haematol.2019.219550","article-title":"Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia","volume":"105","author":"Diop","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2022.07.017_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.pathol.2022.07.017_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/med.20139","article-title":"\"FOXO\" in sight: targeting Foxo proteins from conception to cancer","volume":"29","author":"Maiese","year":"2009","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pathol.2022.07.017_bib52","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3389\/fimmu.2018.02105","article-title":"Mechanisms of regulated and dysregulated CARD11 signaling in adaptive immunity and disease","volume":"9","author":"Bedsaul","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2022.07.017_bib53","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pathol.2022.07.017_bib54","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjh.15063","article-title":"Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease","volume":"183","author":"Ma\u0142ecka","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2022.07.017_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1087057115617456","article-title":"Modulation of NF-\u03baB signaling as a therapeutic target in autoimmunity","volume":"21","author":"Herrington","year":"2016","journal-title":"J\u00a0Biomol Screen"},{"key":"10.1016\/j.pathol.2022.07.017_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2022.07.017_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pathol.2022.07.017_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522002653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522002653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:29:35Z","timestamp":1758472175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302522002653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0031302522002653"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2022.07.017","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2022.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}